2024 is hailed as the first year of AI, with various AI application scenarios emerging one after another. How can weLiberate繁琐重复的工作，让Deep Thinking Happen. And these are quietly happening, with Deep Intelligent PharmaWriting-X Product inApplication of Safety Narrative Report WritingFor example,This tool can complete complex report writing at the minute level, improving work efficiency by 87% compared to traditional methods. So, what else in your work can be made more efficient?
Deep Intelligent Pharma Co., Ltd. asks: What is the most frustrating task you've encountered?
A WeChat User's Comment：
The most frustrating thing I've encountered is the constant collection of information, copying of information, organizing reports, and uploading reports, especially when there are too many colleagues involved. Not only is the workload enormous, time-consuming, and energy-draining, but the double-checking process is an absolute nightmare. You can never be sure what bizarre issues might still be lurking unnoticed. And this type of task is everywhere, unavoidable.@Can repetitive and tedious tasks be done by robots?
A Xiaohongshu user commented:My boss asked me to find the most cost-effective service provider. How is that possible? Everyone’s service processes and workloads are pretty much the same. Who knows where the so-called highly cost-effective service providers cut corners, and what happens if there’s a problem?@What are the characteristics of services that offer both cost-effectiveness and quality assurance
Deep Intelligent Pharma Co., Ltd.: Whether it is the automation of work processes or the demand for cost savings, relying on traditional logic routes is difficult to change. It is necessary to carry out a paradigm shift. For cumbersome work processes, with the help of large AI models, tasks with certain logical rules can be automated. Automation reduces the cost required for tasks, and the reduction in cost leads to an improvement in cost-effectiveness. Deep Intelligent Pharma, based on the latest large AI models combined with an extensive internal database, accelerates this process.
1. Registration translation is not only 10 times faster, but also saves up to 62%.: Our registration document translation services are not only fast but also cost-effective, covering various types of documents in pharmaceutical development. We help clients complete registration applications quickly while significantly reducing costs. According to internal statistics, we have saved clients up to 62% of their annual translation budget, accelerated speed by up to 10 times, without compromising quality. We have served over 700 clients globally, completed more than 30,000 projects, cumulatively translated over 1.5 billion words, and assisted clients in completing hundreds of IND, NDA, ANDA, BLA submissions both domestically and internationally. Customer satisfaction reaches as high as 98%.2. Safety Narrative, CSR can help you with automatic writing, improving efficiency by 87%.: We have independently developed a generative AI-native automatic writing platform (Writing-X), which can automate the writing of Safety Narratives, CSRs, and other documents, improving writing efficiency and accuracy while freeing you from tedious tasks. Our automatic writing platform has been successfully applied to over 100 projects, increasing the efficiency of Safety Narrative writing by more than 87% on average compared to traditional manual writing, with an accuracy rate of over 95%.3. AI Real-Time Simultaneous Interpretation and One-Click Report Generation Solution: We also provide AI simultaneous interpretation services, utilizing the most advanced speech recognition and AI translation technologies to achieve real-time translation. With one click at the end of the meeting, it can generate press releases, meeting minutes, summaries, and synchronized rewrites of CSR, improving meeting efficiency and communication effectiveness. Deep Intelligent Pharma's AI simultaneous interpretation service has received positive customer feedback, greatly enhancing meeting efficiency and communication results while significantly reducing costs and the quality instability brought by human simultaneous interpretation.4. Pharmacovigilance/Medical Device Vigilance Solution Saves Clients at Least 35% on Database Costs: We have developed intelligent AI management platforms such as DEEP-PV for pharmacovigilance and device vigilance, which can achieve safety monitoring and risk assessment of drugs and devices, improving product quality and safety. Deep Intelligent Pharma's pharmacovigilance/device vigilance solutions support the NMPA, FDA, and EMA regional E2B R3 standards. These solutions have been successfully applied to hundreds of clinical Phase I, II, III, IIT, and BE projects, serving over a hundred post-marketing customers and saving clients more than 35% of their database-related expenses.5. Clinical Integrated Solution: Enhancing Efficiency and Quality through Inter-System Data Connectivity: We provide an integrated clinical solution, including EDC, clinical PV, CTMS, eTMF, and human genetic resource management systems, achieving full-process digital management of clinical trials. The interconnectivity between systems enhances trial efficiency and quality. Deep Intelligent Pharma's integrated clinical solution has been successfully applied to some MNC clients and overseas CROs.6. The system meets the quality standards.: Possesses ISO9001 Quality Management System Certification, ISO17100 Translation Service Management System Certification, ISO20000 Information Technology Service Management System Certification, ISO27001 Information Security Management System Certification, ISO27017 Cloud Service Information Security Management System Certification, ISO27018 Cloud Privacy Protection Management System Certification, ISO27701 Privacy Information Security Management System Certification, and Public Security Bureau Level 3 Certification, etc.
About Deep Intelligent PharmaDeep Intelligent Pharma was founded in 2017 and operates simultaneously in Singapore, China, and Japan, with paid-in registered capital exceeding 100 million RMB. The company is committed to using artificial intelligence technology to reduce costs and improve efficiency across the entire pharmaceutical development chain ("efficiency" first). Deeply focused on text intelligence, the company has independently developed generative artificial intelligence (AIGC)-native automatic writing (Writing-X) and automatic translation (Translation-X) platforms, covering all document types in pharmaceutical development. It also provides industry-leading registration document translation and writing services. Additionally, the company has independently developed an AIGC-powered intelligent management platform, including pharmacovigilance DEEP-PV, EDC, CTMS, eTMF, registration document management system, e-CTD, and human genetic resource management system, among others. Deep Intelligent Pharma is currently serving over 700 pharmaceutical companies and CRO clients globally, with its translation services holding a leading market share.
If you are interested in cooperation, please feel free to contact us.
Official Website: www.dip-ai.com
Contact: Mr. Wu
Phone: +86 18640069206
Email: bd@dip-ai.com
